Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects
1 other identifier
interventional
84
1 country
10
Brief Summary
The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks. A second purpose is to evaluate the safety of the drug.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Mar 2005
Shorter than P25 for phase_2
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
June 30, 2005
CompletedFirst Posted
Study publicly available on registry
July 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedFebruary 19, 2007
June 1, 2006
June 30, 2005
February 16, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clearance of treated wart(s)
Secondary Outcomes (2)
Partial clearance of treated wart(s)
Wart recurrence
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of common warts
- Ages between 3 to 11
You may not qualify if:
- Other types of wart(s), ie. plantar
- Currently participating in another clinical study
- Chronic viral hepatitis B or C
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Children's Clinic of Jonesboro, PA
Jonesboro, Arkansas, 72401, United States
University of California - San Francisco
San Francisco, California, 94143, United States
Longmont Clinic/Longmont Medical Research Network
Longmont, Colorado, 80501, United States
Mercy Health Research
St Louis, Missouri, 63141, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Rhode Island Hospital - Jane Brown Building
Providence, Rhode Island, 02903, United States
DermResearch, Inc.
Austin, Texas, 78759, United States
Alpine Pediatrics
Pleasant Grove, Utah, 84062, United States
Walla Walla Clinic
Walla Walla, Washington, 99362, United States
Advanced Healthcare
Milwaukee, Wisconsin, 53209, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
June 30, 2005
First Posted
July 1, 2005
Study Start
March 1, 2005
Study Completion
April 1, 2006
Last Updated
February 19, 2007
Record last verified: 2006-06